Drug Profile
Research programme: farnesoid X receptor agonists - Roche
Alternative Names: FXR agonists - RocheLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Benzimidazoles; Indazoles; Pyrazoles; Pyridines; Small molecules
- Mechanism of Action Farnesoid X-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Metabolic-disorders in Switzerland (PO)
- 30 Mar 2011 Preclinical trials in Metabolic disorders in Switzerland (PO)